Vile, Richard

Oncolytic virotherapy as immunotherapy

Melcher, A., Harrington, K., & Vile, R. (2021) · Science

Virus-based gene therapy researchImmunotherapy and Immune Responses

Cited by 133

Oncolytic virus-derived type I interferon restricts CAR T cell therapy

Evgin, L., Huff, A. L., Wongthida, P., Thompson, J., Kottke, T., Tonne, J., Schuelke, M., Ayasoufi, K., Driscoll, C. B., Shim, K. G., et al. (2020) · Nature Communications

CAR-T cell therapy researchVirus-based gene therapy research

Cited by 128

Retroviruses as vectors

Vile, R. G., & Russell, S. J. (1995) · British Medical Bulletin

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 114

Gene Therapy to Manipulate Effector T Cell Trafficking to Tumors for Immunotherapy

Gough, M., Crittenden, M., Thanarajasingam, U., Sanchez-Perez, L., Thompson, J., Jevremovic, D., & Vile, R. (2005) · The Journal of Immunology

Immunotherapy and Immune ResponsesChemokine receptors and signaling

Cited by 60